
The episode discusses strategies for pharmaceutical and life sciences companies to manage global operations and integrate into international markets effectively.
How can pharmaceutical, MedTech, and life sciences companies structure global operations capable of supporting sustainable international growth, regulatory consistency, and successful market integration? Global expansion is no longer only a commercial opportunity. For companies operating in highly regulated sectors, entering and integrating international markets requires strategic coordination between regulatory affairs, quality systems, supply chain management, local partnerships, risk governance, and operational execution. In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, explores the strategic role of Global Operations Management and the practical approaches companies should consider when expanding across different jurisdictions. The discussion examines how organizations can move from fragmented international activity to structured, resilient, and coherent global operations. You will gain a clearer understanding of: How global operations management supports international expansion in regulated healthcare sectors; Why regulatory alignment and local adaptation must work together when entering new markets; How supply chain…
Explore listener stats, chart rankings, contacts and more on the International Pharma Talks podcast page.